Treatment for Adults with Type 2 Diabetes

Diagnosis and Classification

The American College of Physicians recommends classifying a 40-year-old patient with newly diagnosed diabetes and no mentioned complications as having relatively healthy status with good life expectancy, warranting an A1C target of <7% 2

The American Diabetes Association recommends metformin as the first-line agent for patients with type 2 diabetes, as it is safe, inexpensive, reduces risks of microvascular complications, cardiovascular events, and death, and is weight neutral without causing hypoglycemia 1

The American Diabetes Association supports A1C <7% for most adults to reduce microvascular and macrovascular complications 3
A target A1C <7% is appropriate for a 40-year-old patient with newly diagnosed diabetes, no mentioned complications, and good life expectancy 1, 2

The American Diabetes Association recommends rechecking A1C in 3 months to assess response to metformin therapy 1
Vitamin B12 levels should be monitored periodically (annually or biannually) as metformin use is associated with vitamin B12 deficiency and potential worsening of neuropathy symptoms 1
Renal function should be assessed before starting metformin and periodically thereafter; metformin is safe with eGFR ≥30 mL/min/1.73 m² 1

If A1C remains ≥8.5% (≥1.5% above goal) after 3 months of metformin monotherapy, a second agent, preferably a GLP-1 receptor agonist or SGLT2 inhibitor, should be added based on cardiovascular risk factors and patient preferences 1

The American College of Physicians recommends not delaying pharmacologic treatment with lifestyle modifications alone at an A1C level of 6.7%; metformin should be started immediately alongside lifestyle interventions 1
Insulin or sulfonylureas should not be started as first-line therapy in patients without severe hyperglycemia (A1C ≥10% or glucose ≥300 mg/dL with symptoms) 1
Overly aggressive initial targets that increase hypoglycemia risk should be avoided; A1C <7% is appropriate, and attempting to achieve <6% may not provide additional benefit and increases treatment burden 2
Comprehensive diabetes education, including glucose monitoring (if indicated), dietary counseling, physical activity recommendations, and screening for complications, should not be forgotten 1